decisionhealth Newsletters, Part B News - 2006 Issue 4 (April)
Troubled CAP drug initiative misses key deadline
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s delayed rollout of the competitive acquisition program (CAP) for Part B drugs, including missed deadlines for election procedures, vendor announcements, and the planned launch timeline. It is relevant to physicians, specialty practices, practice managers, and medical billing professionals who follow Medicare Part B drug acquisition policy and CMS program implementation. The piece also discusses limited physician interest, vendor confidentiality, and the administrative steps CMS had planned for participation.
Why This Topic Matters
Changes to Medicare Part B drug purchasing and billing programs can affect practice operations, vendor contracting, and how physician offices prepare for drug acquisition under CMS initiatives. This update helps readers understand the status of a major federal program that could alter workflow and participation decisions.
What You Will Learn
- The current status of CMS’s competitive acquisition program for Part B drugs
- Why the program’s rollout is being delayed
- What types of stakeholders are affected by the program timing
- How CMS’s vendor and enrollment process is being handled at a high level
Who Should Read This
- Physicians
- Specialty practices
- Practice managers
- Medical billing professionals
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com